The imperative of research and development in Nigeria: lessons from the COVID-19 pandemic Online publication date: Tue, 20-Jul-2021
by Morolake Bolaji; John O. Adeoti; Joshua Adeyemi Afolabi
International Journal of Technological Learning, Innovation and Development (IJTLID), Vol. 13, No. 2, 2021
Abstract: The advent of the coronavirus disease (COVID-19) threw the world into pandemonium as most countries were unprepared for its sudden outbreak. Industrialised countries swung into action by applying technology to monitor COVID-19 cases while accentuating research and development (R&D) activities to develop COVID-19 vaccines and drugs. However, Nigeria has not significantly contributed to global research efforts aimed at addressing the challenges posed by the pandemic. This paper applied a case study approach and situational analysis to examine the state of R&D in Nigeria relative to other economies. The paper goes on to investigate the impact of COVID-19 on Nigeria's health sector and the economy at large while emphasising the imperativeness of R&D in effectively handling future outbreaks and, thus, achieving economic and technological catch-up. This study revealed that Nigeria remains a laggard in R&D spending as well as R&D activities, particularly in the health sector as exposed by the recent COVID-19 pandemic. This further reinforces the imperative for Nigeria to significantly and urgently increase its R&D spending not only to combat subsequent health challenges but also to facilitate rapid structural transformation and economic development.
Existing subscribers:
Go to Inderscience Online Journals to access the Full Text of this article.
If you are not a subscriber and you just want to read the full contents of this article, buy online access here.Complimentary Subscribers, Editors or Members of the Editorial Board of the International Journal of Technological Learning, Innovation and Development (IJTLID):
Login with your Inderscience username and password:
Want to subscribe?
A subscription gives you complete access to all articles in the current issue, as well as to all articles in the previous three years (where applicable). See our Orders page to subscribe.
If you still need assistance, please email subs@inderscience.com